BMC Medical Co., Ltd. (SHE:301367)
China
· Delayed Price · Currency is CNY 67.26
+0.26 (0.39%)
At close: Apr 29, 2026
BMC Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2019 |
| Net Income | 192.15 | 225.66 | 155.38 | 297.34 | 380.3 | 145.68 | Upgrade
|
| Depreciation & Amortization | 21.42 | 21.42 | 21.93 | 19.4 | 8.74 | 8.81 | Upgrade
|
| Other Amortization | 6.07 | 6.07 | 4.91 | 3.93 | 2.29 | 1.78 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.26 | -0.26 | -0.19 | -0.48 | -0.02 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.83 | 0.83 | 3.06 | 0.02 | 3.77 | 0.25 | Upgrade
|
| Loss (Gain) From Sale of Investments | -50.48 | -50.48 | -60.36 | -57.17 | -14.82 | -8.46 | Upgrade
|
| Provision & Write-off of Bad Debts | 2.4 | 2.4 | 2.75 | 2.8 | - | - | Upgrade
|
| Other Operating Activities | 63.26 | 36.37 | 13.96 | 13.97 | -10.78 | 3.87 | Upgrade
|
| Change in Accounts Receivable | -135.35 | -135.35 | -67.95 | -21.97 | -63.53 | -19.68 | Upgrade
|
| Change in Inventory | -23 | -23 | 2.86 | 75.06 | -86.08 | -69.78 | Upgrade
|
| Change in Accounts Payable | 42.03 | 42.03 | 80.68 | -183.63 | 158.51 | 42.54 | Upgrade
|
| Change in Other Net Operating Assets | 13.55 | 13.55 | - | - | - | - | Upgrade
|
| Operating Cash Flow | 123.54 | 130.16 | 154.08 | 151.11 | 375.21 | 104.4 | Upgrade
|
| Operating Cash Flow Growth | 2.81% | -15.53% | 1.97% | -59.73% | 259.39% | -60.96% | Upgrade
|
| Capital Expenditures | -35.35 | -32.22 | -15.93 | -24.12 | -23.75 | -10.03 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.15 | 0.15 | 0.48 | 0.16 | 0.08 | 0 | Upgrade
|
| Cash Acquisitions | - | - | - | - | 5.86 | - | Upgrade
|
| Investment in Securities | 272.86 | 763.09 | -638.12 | 268.44 | -1,859 | -164.85 | Upgrade
|
| Other Investing Activities | 75.72 | 88.2 | 52.46 | 57.43 | 1 | - | Upgrade
|
| Investing Cash Flow | 313.38 | 819.22 | -601.1 | 301.9 | -1,876 | -174.87 | Upgrade
|
| Short-Term Debt Issued | - | 447.31 | 384.49 | - | - | - | Upgrade
|
| Total Debt Issued | 298.31 | 447.31 | 384.49 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -706.47 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -12.39 | -11.44 | -9.76 | -3.12 | -1.38 | Upgrade
|
| Total Debt Repaid | -560.8 | -718.86 | -11.44 | -9.76 | -3.12 | -1.38 | Upgrade
|
| Net Debt Issued (Repaid) | -262.49 | -271.55 | 373.05 | -9.76 | -3.12 | -1.38 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 1,764 | - | Upgrade
|
| Repurchase of Common Stock | -2.02 | -2.02 | -42.26 | - | - | - | Upgrade
|
| Common Dividends Paid | -40.97 | -41.94 | -65.79 | -128 | - | -28.8 | Upgrade
|
| Other Financing Activities | -10.24 | -27.07 | -25.07 | -2 | -25.86 | - | Upgrade
|
| Financing Cash Flow | -315.72 | -342.58 | 239.93 | -139.76 | 1,735 | -30.18 | Upgrade
|
| Foreign Exchange Rate Adjustments | -19.38 | -3.2 | 4.36 | -0.41 | 7.59 | -3.67 | Upgrade
|
| Net Cash Flow | 101.82 | 603.6 | -202.73 | 312.84 | 241.89 | -104.32 | Upgrade
|
| Free Cash Flow | 88.19 | 97.94 | 138.16 | 126.98 | 351.46 | 94.38 | Upgrade
|
| Free Cash Flow Growth | -15.50% | -29.11% | 8.80% | -63.87% | 272.41% | -62.55% | Upgrade
|
| Free Cash Flow Margin | 7.33% | 8.45% | 16.38% | 11.31% | 24.83% | 14.24% | Upgrade
|
| Free Cash Flow Per Share | 0.99 | 1.10 | 1.55 | 1.42 | 4.96 | 1.41 | Upgrade
|
| Cash Income Tax Paid | 50.73 | 62.03 | 3.49 | -5.79 | -77.83 | 2.23 | Upgrade
|
| Levered Free Cash Flow | 32.37 | 69.93 | 94.07 | 44.8 | 242.34 | 49.67 | Upgrade
|
| Unlevered Free Cash Flow | 35.47 | 73.03 | 95.85 | 45.65 | 242.63 | 49.8 | Upgrade
|
| Change in Working Capital | -111.84 | -111.84 | 12.66 | -128.7 | 5.73 | -47.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.